FIT Biotech Oy: Changes in FIT Biotech's Board of Directors

Tampere, FINLAND

FIT Biotech Oy 
Company release 3.1.2019 at 15:30 EET

Changes in FIT Biotech's Board of Directors

Juhani Pitkäkoski has resigned because of personal reasons from FIT Biotech Oy's ("Company", FITBIO: FN Finland) Board of Directors. Pitkäkoski has served as a member of FIT Biotech's Board of Directors since 2018.

Chitra Bharucha, Chairman of the Board of Directors, comments:
 "I want to thank Juhani for the work he has done in the company's Board of Directors."

FIT Biotech Oy
Board of Directors

For further information:
Chitra Bharucha
Chairman of the Board of Directors
Tel: +44 7736 679347

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

FIT Biotech in brief 

FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines. 

FIT Biotech applies its GTU® technology in its development projects, which at the time include gene-based treatments, genetic vaccines and research collaboration. Application areas include cancer (gene therapy) and infectious diseases such as HIV.

FIT Biotech K-shares are listed on the First North Finland market maintained by Nasdaq Helsinki Ltd.


Nasdaq Helsinki
Principal media